Immune correlates in a Phase II clinical trial with ipilimumab in combination with finite androgen deprivation therapy in patients with metastatic non-castrate prostate cancer. Issue 2 (December 2015) - Subudhi, Sumit; Aparicio, Ana; Gao, Jianjun; Zurita, Amado; John, Araujo; Logothetis, Christopher; Rao, Brinda; Vence, Luis; Allison, James; Emerson, Ryan; Yusko, Erik; Vignali, Marissa; et al.